Receptive Bio Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 2

Receptive Bio General Information

Description

Operator of a biotechnology company intended to enable selective drug transport to the brain. The company utilizes next-generation blood-brain barrier shuttles and novel receptor targeting to provide central nervous system therapeutics, alzheimer's disease treatments, therapeutic delivery technology, and drug delivery research, enabling pharmaceutical firms to deliver effective treatments for neurological disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Basel
  • Switzerland
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Basel
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Receptive Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Jul-2025 Completed Startup
To view Receptive Bio’s complete valuation and funding history, request access »

Receptive Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Receptive Bio Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Roche Venture Fund Corporate Venture Capital Minority
Wilson Hill Ventures Venture Capital Minority
To view Receptive Bio’s complete investors history, request access »

Receptive Bio FAQs

  • When was Receptive Bio founded?

    Receptive Bio was founded in 2023.

  • Where is Receptive Bio headquartered?

    Receptive Bio is headquartered in Basel, Switzerland.

  • What is the size of Receptive Bio?

    Receptive Bio has 11 total employees.

  • What industry is Receptive Bio in?

    Receptive Bio’s primary industry is Drug Delivery.

  • Is Receptive Bio a private or public company?

    Receptive Bio is a Private company.

  • What is Receptive Bio’s current revenue?

    The current revenue for Receptive Bio is .

  • Who are Receptive Bio’s investors?

    Roche Venture Fund and Wilson Hill Ventures have invested in Receptive Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process